Cytologic and histologic correlation of atypical glandular cells of undetermined significance

Journal of Korean Medical Science

Volumn 16, Issue 2, 2001, Pages 214-219

  Ha, Seung Yeon ^a   Cho, Hyuni ^a   Oh, Young Ha ^a   Lee, Jong Min ^a   Suh, Kwang Sun ^b  

^a Gachon University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Atypical Glandular Cells of Undetermined Significance; Cervix Uteri; Cytology; Vaginal Smears

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; PATHOLOGY; PREVALENCE; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADENOCARCINOMA; ADULT; AGED; BIOPSY; CERVIX UTERI; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035317085     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.2.214     Document Type: Article

References (28)

1. International Academy of Cytology. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: revised after the Second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993; 37: 115-24.
2. DiTomasso JP, Ramzy I, Mody DR. Glandular lesions of the cervix: validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma. Acta Cytol 1996; 40: 1127-35.
3. Raab SS, Isacson C, Layfield LJ, Lenel JC, Slagel DD, Thomas PA. Atypical glandular cells of undetermined significance: cytologic criteria to separate clinically significant from benign lesions. Am J Clin Pathol 1995; 104: 574-82.
4. Cenci M, Mancini R, Nofroni J, Vechione A. Endocervical atypical glandular cells of undetermined significance: I. Morphometric and cytologic characterization of cases that "Cannot rule out adenocarcinoma in situ". Acta Cytol 2000; 44: 319-26.
5. Cenci M, Mancini R, Nofroni I, Vecchione A. Endocervical atypical glandular cells of undetermined significance: II. Morphometric and cytologic analysis of nuclear features useful in characterizing differently correlated subgroups. Acta Cytol 2000; 44: 327-31.
6. Selvaggi SM. Cytologic features of squamous cell carcinoma in situ involving endocervical gland in endocervical cytobrush specimens. Acta Cytol 1994; 38: 687-92.
7. Novotny DB, Maygarden SJ, Johnson DE, Frable WJ. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 1992; 36: 1-10.
8. Kennedy AW, Salmieri SS, Wirth SL. Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996; 63: 14-8.
9. Bottles K, Reiter RC, Steiner AL, Zaleski S, Bedrossian CW, Johnson SR. Problems encountered with the Bethesda System: the University of Iowa experience. Obstet Gynecol 1991; 78: 410-4.
10. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 1992; 79: 101-4.
11. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997; 65: 314-8.
12. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998; 91: 278-82.
13. Manetta A, Keefe K, Lin F, Ahdoot D, Kaleb V. Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999; 180: 883-8.
14. Kurman RJ, Solomon K. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. New York: Springer Verlag, 1994; 30-8.
15. Korean Society for Pathologist. Pathology. 4th ed. Seoul: Komoonsa, 2000; 189-90.
16. Korean Society for Obstetrics and Gynecology. Annual repotrt of gynecologic cancer registry program in Korean for 1997. Korean J Obstet Gynecol 2000; 13: 547-85.
17. Shingleton HM, Orr JW, JR. Cancer of the cervix. 1st ed. Philadelphia: 1 JB Lippincott, 1995; 9-12.
18. Veljovich DS, Stoler MH, Andersen WA, Covell JL, CT, Rice LW. Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study. Am J Obstet Gynecol 1998; 179: 382-90.
19. Cooper K, Herrington CS, Lo ES, Evans MF, McGee JO. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol 1992; 45: 382-4.
20. Duggan MA, Benoit JL, McGregor SE, Inoue M, Nation JG, Stuart GC. Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification. Int J Gynecol Pathol 1994; 13: 143-9.
21. Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989; 8: 321-30.
22. Kenny MB, Unger ER, Chenggis ML, Costa MJ. In situ hybridization for human papillomavirus DNA in uterine adenosquamous carcinoma with glassy cell features ("glassy cell carcinoma"). Am J Clin Pathol 1992; 98: 180-7.
23. Leminen A, Paavonen J, Vesterinen E, Wahlsrom T, Rantala I, Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991; 95: 647-52.
24. Weaver MG, Abdul-Karim FW, Dale G, Sorensen K, Huang YT. Outcome in mild and moderate cervical dysplasia related to the presence of specific human papillomavirus types. Mod Pathol 1990; 3: 679-83.
25. Stoler MH. The biology of human papillomavirus. Pathol Case Rev 1997; 2: 1-13.
26. Nasu I, Meurer W, Fu YS. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int J Gynecol Pathol 1993: 12: 208-18.
27. Taylor RR, Guerrieri JP, Nash JD, Henry MR, O'Connor DM. Atypical cervical pathology: colposcopic follow-up using the Bethesda System. J Reprod Med 1993; 38: 443-7.
28. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda System. Am J Obstet Gynecol 1997; 177: 1188-95.